Research graph
References from hdmax2, an R package to perform high dimension mediation analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
10.1038/s41598-019-38897-w · 2019 · External reference
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations
10.1037//0022-3514.51.6.1173 · 1986 · External reference
Challenges Raised by Mediation Analysis in a High-Dimension Setting
10.1289/ehp6240 · 2020 · External reference
The Scree Test For The Number Of Factors
10.1207/s15327906mbr0102_10 · 1966 · External reference
LFMM 2: Fast and Accurate Inference of Gene-Environment Associations in Genome-Wide Studies
10.1093/molbev/msz008 · 2019 · External reference
Methods for mediation analysis with high-dimensional DNA methylation data: Possible choices and comparisons
10.1371/journal.pgen.1011022 · 2023 · External reference
A multiple-testing procedure for high-dimensional mediation hypotheses
10.1080/01621459.2020.1765785 · 2022 · External reference
Global test for high-dimensional mediation: Testing groups of potential mediators
10.1002/sim.8199 · 2019 · External reference
Hypoxia in multiple sclerosis; is it the chicken or the egg?
10.1093/brain/awaa427 · 2020 · External reference
Sex and gender issues in multiple sclerosis
10.1177/1756285613488434 · 2013 · External reference
A general approach to causal mediation analysis
10.1037/a0020761 · 2010 · External reference
High-Dimensional Mediation Analysis: A New Method Applied to Maternal Smoking, Placental Dna Methylation, and Birth Outcomes
10.1289/ehp11559 · 2023 · External reference
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
10.1093/brain/awaa421 · 2020 · External reference
Fast gene set enrichment analysis
10.1101/060012 · 2021 · External reference
High-dimensional mediation analysis: Unraveling pathways linking external exposures to health outcomes
10.24072/pci.genomics.100416 · 2025 · External reference
The Molecular Signatures Database (MSigDB) hallmark gene set collection
10.1016/j.cels.2015.12.004 · 2015 · External reference
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
10.1186/s13059-014-0550-8 · 2014 · External reference
High-dimensional mediation analysis in survival models
10.1371/journal.pcbi.1007768 · 2020 · External reference
Emerging roles of p53 and other tumour-suppressor genes in immune regulation
10.1038/nri.2016.99 · 2016 · External reference
Subtypes of Breast Cancer
2022 · External reference
The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
10.1016/j.jtauto.2021.100123 · 2021 · External reference
hdmax2: R package hdmax2 performs high dimension mediation analysis
2025 · External reference
Mediation analysis in epidemiology: methods, interpretation and bias
10.1093/ije/dyt127 · 2013 · External reference
FWER and FDR control when testing multiple mediators
10.1093/bioinformatics/bty064 · 2018 · External reference
Asymptotic Confidence Intervals for Indirect Effects in Structural Equation Models
10.2307/270723 · 1982 · External reference
mediation: R Package for Causal Mediation Analysis
10.18637/jss.v059.i05 · 2014 · External reference
Sex differences in brain atrophy in multiple sclerosis
10.1186/s13293-020-00326-3 · 2020 · External reference
The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment
10.1186/s12967-024-04899-0 · 2024 · External reference
10.1016/j.csbj.2021.05.042 · 2021 · Admitted local publication
Mediation analysis for survival data with high-dimensional mediators
10.1093/bioinformatics/btab564 · 2021 · External reference
Estimating and testing high-dimensional mediation effects in epigenetic studies
10.1093/bioinformatics/btw351 · 2016 · External reference
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
10.1038/s41590-023-01588-w · 2023 · External reference
